Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist.
Saved in:
| Title: | Predicting Antigen-Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist. |
|---|---|
| Authors: | Perez MAS; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Molecular Modeling Group, SIB Swiss Institute of Bioinformatics, University of Lausanne, Quartier UNIL-Sorge, Bâtiment Amphipole, Lausanne, CH-1015, Switzerland., Chiffelle J; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Bobisse S; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Mayol-Rullan F; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Molecular Modeling Group, SIB Swiss Institute of Bioinformatics, University of Lausanne, Quartier UNIL-Sorge, Bâtiment Amphipole, Lausanne, CH-1015, Switzerland., Bugnon M; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Molecular Modeling Group, SIB Swiss Institute of Bioinformatics, University of Lausanne, Quartier UNIL-Sorge, Bâtiment Amphipole, Lausanne, CH-1015, Switzerland., Bragina ME; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Molecular Modeling Group, SIB Swiss Institute of Bioinformatics, University of Lausanne, Quartier UNIL-Sorge, Bâtiment Amphipole, Lausanne, CH-1015, Switzerland., Arnaud M; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Sauvage C; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Barras D; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Laniti DD; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Huber F; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Bassani-Sternberg M; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Coukos G; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland.; Department of Oncology, Immuno-Oncology Service, Lausanne University Hospital, Lausanne, CH-1011, Switzerland., Harari A; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Center for Cell Therapy, CHUV-Ludwig Institute, Lausanne, CH-1011, Switzerland., Zoete V; Department of Oncology, Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Agora Cancer Research Center, Lausanne, CH-1005, Switzerland.; Molecular Modeling Group, SIB Swiss Institute of Bioinformatics, University of Lausanne, Quartier UNIL-Sorge, Bâtiment Amphipole, Lausanne, CH-1015, Switzerland. |
| Source: | Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Oct; Vol. 11 (40), pp. e2405949. Date of Electronic Publication: 2024 Aug 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844 (Electronic) Linking ISSN: 21983844 NLM ISO Abbreviation: Adv Sci (Weinh) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2198-3844 |
|---|---|
| DOI: | 10.1002/advs.202405949 |
